These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36990198)

  • 21. Abnormal podocyte TRPML1 channel activity and exosome release in mice with podocyte-specific Asah1 gene deletion.
    Li G; Huang D; Bhat OM; Poklis JL; Zhang A; Zou Y; Kidd J; Gehr TWB; Li PL
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158856. PubMed ID: 33221496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon‑like peptide‑1 protects mouse podocytes against high glucose‑induced apoptosis, and suppresses reactive oxygen species production and proinflammatory cytokine secretion, through sirtuin 1 activation in vitro.
    Shi JX; Huang Q
    Mol Med Rep; 2018 Aug; 18(2):1789-1797. PubMed ID: 29845208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
    Jin J; Gong J; Zhao L; Li Y; He Q
    Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 26. Nicotine, smoking, podocytes, and diabetic nephropathy.
    Jaimes EA; Zhou MS; Siddiqui M; Rezonzew G; Tian R; Seshan SV; Muwonge AN; Wong NJ; Azeloglu EU; Fornoni A; Merscher S; Raij L
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F442-F453. PubMed ID: 33459165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes.
    Wu X; Gao Y; Xu L; Dang W; Yan H; Zou D; Zhu Z; Luo L; Tian N; Wang X; Tong Y; Han Z
    Sci Rep; 2017 Aug; 7(1):9371. PubMed ID: 28839221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 31. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-503 contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
    Zha F; Bai L; Tang B; Li J; Wang Y; Zheng P; Ji T; Bai S
    J Cell Biochem; 2019 Aug; 120(8):12574-12581. PubMed ID: 30834596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miRNA-93-5p in exosomes derived from M2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting Toll-like receptor 4.
    Wang Z; Sun W; Li R; Liu Y
    Bioengineered; 2022 Mar; 13(3):7683-7696. PubMed ID: 35291915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of transcription factor acetylation in diabetic kidney disease.
    Liu R; Zhong Y; Li X; Chen H; Jim B; Zhou MM; Chuang PY; He JC
    Diabetes; 2014 Jul; 63(7):2440-53. PubMed ID: 24608443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
    Wang Y; Feng F; He W; Sun L; He Q; Jin J
    Bioengineered; 2022 Jan; 13(1):774-788. PubMed ID: 34847832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS.
    Li J; Sun YBY; Chen W; Fan J; Li S; Qu X; Chen Q; Chen R; Zhu D; Zhang J; Wu Z; Chi H; Crawford S; Oorschot V; Puelles VG; Kerr PG; Ren Y; Nilsson SK; Christian M; Tang H; Chen W; Bertram JF; Nikolic-Paterson DJ; Yu X
    EMBO Rep; 2020 Feb; 21(2):e48781. PubMed ID: 31916354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of mitochondrial fission factor in podocyte injury in diabetic nephropathy.
    Xiao M; Kong ZL; Che K; Hu JX; Li Y; Huang YJ; Guo H; Qi MM; Chi JW; Wang YG
    Biochem Biophys Res Commun; 2022 Oct; 624():40-46. PubMed ID: 35932578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise training ameliorates early diabetic kidney injury by regulating the H
    Yang L; Li DX; Cao BQ; Liu SJ; Xu DH; Zhu XY; Liu YJ
    FASEB J; 2021 Sep; 35(9):e21823. PubMed ID: 34396581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
    Gao J; Liang Z; Zhao F; Liu X; Ma N
    Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. METTL14 aggravates podocyte injury and glomerulopathy progression through N
    Lu Z; Liu H; Song N; Liang Y; Zhu J; Chen J; Ning Y; Hu J; Fang Y; Teng J; Zou J; Dai Y; Ding X
    Cell Death Dis; 2021 Sep; 12(10):881. PubMed ID: 34580283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.